References
- 1. Brzozowski T. et al.: Physiological mediators in nonsteroidal antiinflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. J Physiol Pharmacol., 59, 2, 2008.
- 2. Filaretova L.: Gastroprotective role of glucocorticoids during NSAID-induced gastropathy. Curr Pharm Des., 19, 29, 2013.
- 3. Fomenko I.S. et al.: Parameters of NO synthase system of gastric mucosa in rats under stress conditions and inhibition of cyclooxygenase. Fiziol Zh., 60, 2, 2014.
- 4. Fomenko I. et al.: Effects of conventional and hydrogen sulfidereleasing non-steroidal anti-inflammatory drugs in rats with stressinduced and epinephrine-induced gastric damage. Stress, 17(6), 528, 2014.
- 5. Geyer J.W., Dabich D.: Rapid method for determination of arginase activity in tissue homogenates. Anal Biochem., 39(2), 412, 1971.
- 6. Jaworek J. et al.: Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. J Physiol Pharmacol., 52, 1, 2001.
- 7. Konturek P.C. et al.: Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. J Physiol Pharmacol., 61, 4, 2010.
- 8. Kudryavtsev K.V. et al.: Pharmacological correction of stressinduced gastric ulceration by novel small-molecule agents with antioxidant profile. Scientific World Journal, Article ID 217039, 2014.
- 9. Lunberg J.О., Weitzberg E.: Biology of nitrogen oxides in the gastrointestinal tract. Gut, 62(4), 616, 2013.
- 10. Martel-Pelletier J., Lajeunesse D., Reboul P.: Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective nonsteroidal anti-inflammatory drugs. Ann Rheum Dis, 62(6), 501, 2003.
- 11. Mollace V et al. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev., 57(2),217, 2005.
- 12. Musumba C., Pritchard D.M., Pirmohamed M.: Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther, 30(6), 517, 2009.
- 13. Sklyarov A.Y., Panasyuk N.B., Fomenko I.S.: Role of nitric oxidesynthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. J Physiol Pharmacol., 62, 65, 2011.
- 14. Takeuchi K.: Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. World J Gastroenterol. 18, 18, 2012.
- 15. Turkevych N.M.: Vvedenskij V.M., Petlichnaya L.P. Ukr. Khim. Zh. (Russ. Ed.), 1961.